SG/PUT/FRESENIUS MEDICAL CARE/40/0.1/20.12.24 Stock

Warrant

DE000SV1E947

Delayed Deutsche Boerse AG 14:07:53 2024-07-04 EDT
0.54 EUR 0.00% Intraday chart for SG/PUT/FRESENIUS MEDICAL CARE/40/0.1/20.12.24
Current month-3.57%
1 month+28.57%
Date Price Change
24-07-04 0.54 0.00%
24-07-03 0.54 -1.82%
24-07-02 0.55 +1.85%
24-07-01 0.54 -3.57%
24-06-28 0.56 +1.82%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 02:07 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Société Générale Société Générale
WKN SV1E94
ISINDE000SV1E947
Date issued 2023-02-23
Strike 40
Maturity 2024-12-20 (169 Days)
Parity 10 : 1
Emission price 0.65
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.05
Lowest since issue 0.3
Spread 0.02
Spread %3.57%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.61 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.25%
Consensus